FBN1 and Marfan syndrome: Thus, single FBN1 mutation cannot fully explain the heterogeneity of clinical phenotypes in MFS patients, who can express different pathologies in the eyes, skin, musculoskeletal, cardiovascular, and pulmonary systems.